Event Details

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

KemPharm KP415 Phase 1 Results and KOL Conference Call

Dec 14, 2016 from 4:30 PM to 4:30 PM EST